Joshua Fitch is an editor for Contemporary Pediatrics.
Ritlecitinib demonstrates efficacy in alopecia areata patients 12 years and older
Ritlecitinib could be a suitable treatment option for alopecia areata patients aged 12 years and older following positive results from a recent trial.
Discussing historic pediatric medical breakthroughs
Andrew Lam, MD, retinal surgeon, author, assistant professor, University of Massachusetts Medical School explains what readers can look forward to in his new book, "The Masters of Medicine: Our Greatest Triumphs in the Race to Cure Humanity’s Deadliest Diseases."
Parents believe there are pros and cons to teens having a job
There are mixed feelings when it comes to teenagers having a job, according to over 1000 parents surveyed in a recent C.S. Mott Children’s Hospital National Poll.
FDA approves expansion of primary immunodeficiency medicine for treatment in children
The FDA recently approved Hyqvia, expanding its use to treat pediatric patients with primary immunodeficiency (PI) aged 2 to 16 years.
How insulin changed the way type 1 diabetes was treated in children
Andrew Lam, MD, retinal surgeon, author, assistant professor, University of Massachusetts Medical School discusses the earliest treatments for type 1 diabetes in children, a topic of his new book, "The Masters of Medicine: Our Greatest Triumphs in the Race to Cure Humanity’s Deadliest Diseases," due out April 18, 2023.
Pediatric mental health and social media
Candice Jones, MD, discusses the impact and potential impacts social media has on the lives of children and adolescents, and how it can impact pediatric mental health.
Voluntary recall expanded due to potential undeclared cashews in Peanut Butter Chocolate Crispy Bars
Due to possible undeclared cashews in SimplyProtein’s Peanut Butter Chocolate Crispy Bars, the voluntary recall of the Costco-sold product has been expanded.
Community prevention system reduces handgun prevalence among rural-area adolescents
Over 4400 students participated in this community-randomized trial from 24 communities across 7 states.
2020 spike in SIDS likely due to diagnostic shifting, not COVID-19
Though an increased rate of sudden infant death syndrome (SIDS) occurred from 2019 to 2020, a recent study suggests the increase wasn’t directly related to the COVID-19 pandemic.
Drug-resistant patients have improved health-related quality of life post pediatric epilepsy surgery
At 2 years post-pediatric epilepsy surgery, 72% of patients were seizure-free compared to 33% of medically-treated patients.
Half of meningococcal vaccination appointments delayed or canceled during COVID-19 pandemic
A multi-country survey revealed 50% of meningitis vaccination appointments were delayed or canceled amid the COVID-19 pandemic, highlighting the need for “urgent action” to maintain routine vaccination levels among children, according to survey authors.
Quantifying public-school students with disabilities experiencing homelessness
Eric Rubenstein, PhD, assistant professor, Department of Epidemiology, Boston University School of Public Health, explains why continued data collection for public school students with disabilities that experience homelessness is crucial for better support and care in this population.
Atovaquone oral suspension, USP 750mg/5mL voluntarily recalled for potential Bacillus cereus contamination
With concerns of potential Bacillus cereus contamination, Atovaquone oral suspension, USP 750mg/5mL has been voluntarily recalled by Camber Pharmaceuticals Inc.
CDC: Early autism detection disrupted by COVID-19 pandemic
Data pulled from 11 communities in the Autism and Developmental Disabilities (ADDM) Network demonstrate higher autism prevalence for children aged 8 years.
Verapamil partially preserves beta cell function in children with newly diagnosed type 1 diabetes
According to the study, maintaining modest residual beta cell function in newly diagnosed patients is associated with a lower risk of vascular complications and hypoglycemia.
AAP backs statement to eliminate period poverty, increase youth’s access to menstrual hygiene products
The North American Society for Pediatric and Adolescent Gynecology’s position statement to eliminate period poverty has acquired a recent endorsement from the American Academy of Pediatrics.
Onasemnogene abeparvovec demonstrates long-term durability for SMA patients
Children treated after presenting spinal muscular atrophy (SMA) symptoms maintained all previously achieved motor milestones up to 7.5 years post-dosing.
Leniolisib approved as first treatment for PI3K-delta syndrome in patients 12 years and older
Leniolisib is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.
FDA approves dabrafenib plus trametinib and liquid formulations to treat BRAF V600E low-grade glioma
Pediatric patients with BRAF V600E low-grade glioma as young as 1 year can now be treated with dabrafenib plus trametinib following its FDA approval.
Poll reveals how parents determine risks, punishments, and likelihood of vaping in their children
A recent survey from the C.S. Mott Children’s Hospital National Poll on Children’s Health revealed how addictive parents believe vaping is for children.
Pediatric speech disorder diagnoses more than doubled amid COVID-19 pandemic
Recent data revealed a 110% increase in speech disorder diagnoses for children aged 0 to 12 years in 2022, compared to the pre-pandemic era.
Roflumilast cream 0.15% reduces itch for atopic dermatitis patients 6 years and older
In identical phase 3 trials, roflumilast demonstrated topline positive results, reducing itch in children and adults with mild to moderate AD.
Dupilumab effective for atopic hand and foot dermatitis
In a phase 3 clinical trial, dupilumab met both its primary and key secondary endpoints, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.
Early return to school linked to faster recovery, less symptom burden for concussed children
A study found that children with acute concussions could have less symptom burden with an earlier return to school.
Early initiation, quick escalation to high-intensity drinking can promote screening in adolescents
According to a recently published study, identification of early initiation and quick escalation to high-intensity drinking in adolescents and young adults can increase screenings for these types of behaviors.
Tapinarof cream safe, effective for pediatric atopic dermatitis
Results from a recent phase 3 clinical trial demonstrated topline safety and efficacy results for tapinarof cream, 1% (VTAMA; Dermavant) as a potential treatment for atopic dermatitis in patients 2 years and older.
AAP: Tips for preventing medication poisoning in children
The American Academy of Pediatrics recently released several tips to prevent medication poisoning in young children because of a rise in opioid-related poisonings from 2005 to 2018.
Pediatric mental health tops patient safety threat list
A recent report lists the pediatric mental health crisis as the top patient safety concern following increases in anxiety and depression among children.
2 Clarke Drive Cranbury, NJ 08512